Pulmonary Clinical Trial - Insmed Incorporated - Insmed ASPEN INS1007-301 Study

Multispecialty

Status:

Startup

ClinicalTrials.gov:

NCT04594369

Aspen - Insmed 1007-301

Drug

Brensocatib 10 mg, Brensocatib 25 mg, Placebo

Phase

III